Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Pain × Lidocaine × Clear all

Phase

Status

Completed 6 Unknown 2 Withdrawn 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 1 Operable Breast Cancer 1 Nevus, Pigmented 1 Neoplasms 1 Melanoma 1 Malignant Pleural Neoplasm 1 Liver Neoplasms 1 Breast Neoplasms 1 Agnosia 1

Interventions

tanezumab 1 Yoga 1 Water 1 Radiotherapy 1 Radiofrequency Ablation 1 Lidocaine 1 Ethanol 1 Electroacupuncture 1 Drug Therapy 1 Dexamethasone 1 Calcium Dobesilate 1 Art Therapy 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07034950 2025-09-11

Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation

The First Affiliated Hospital of Xiamen University

Phase 1/2 Active not recruiting

Gastrointestinal

Liver Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡